186 related articles for article (PubMed ID: 9761786)
1. In vitro modulation of primate coronary vascular muscle cell reactivity by ovarian steroid hormones.
Minshall RD; Miyagawa K; Chadwick CC; Novy MJ; Hermsmeyer K
FASEB J; 1998 Oct; 12(13):1419-29. PubMed ID: 9761786
[TBL] [Abstract][Full Text] [Related]
2. Ovarian steroid protection against coronary artery hyperreactivity in rhesus monkeys.
Minshall RD; Stanczyk FZ; Miyagawa K; Uchida B; Axthelm M; Novy M; Hermsmeyer K
J Clin Endocrinol Metab; 1998 Feb; 83(2):649-59. PubMed ID: 9467588
[TBL] [Abstract][Full Text] [Related]
3. Ca2+ release mechanism of primate drug-induced coronary vasospasm.
Miyagawa K; Vidgoff J; Hermsmeyer K
Am J Physiol; 1997 Jun; 272(6 Pt 2):H2645-54. PubMed ID: 9227542
[TBL] [Abstract][Full Text] [Related]
4. Nongenomic vasodilator action of progesterone on primate coronary arteries.
Minshall RD; Pavcnik D; Browne DL; Hermsmeyer K
J Appl Physiol (1985); 2002 Feb; 92(2):701-8. PubMed ID: 11796684
[TBL] [Abstract][Full Text] [Related]
5. Progesterone regulation of vascular thromboxane A(2) receptors in rhesus monkeys.
Minshall RD; Pavcnik D; Halushka PV; Hermsmeyer K
Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1498-507. PubMed ID: 11557538
[TBL] [Abstract][Full Text] [Related]
6. Metabolite ligands of estrogen receptor-beta reduce primate coronary hyperreactivity.
Mishra RG; Stanczyk FZ; Burry KA; Oparil S; Katzenellenbogen BS; Nealen ML; Katzenellenbogen JA; Hermsmeyer RK
Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H295-303. PubMed ID: 16199482
[TBL] [Abstract][Full Text] [Related]
7. Prevention of coronary hyperreactivity in preatherogenic menopausal rhesus monkeys by transdermal progesterone.
Hermsmeyer RK; Mishra RG; Pavcnik D; Uchida B; Axthelm MK; Stanczyk FZ; Burry KA; Illingworth DR; Juan C; Nordt FJ
Arterioscler Thromb Vasc Biol; 2004 May; 24(5):955-61. PubMed ID: 15031127
[TBL] [Abstract][Full Text] [Related]
8. Isoform-specific protein kinase C activity at variable Ca2+ entry during coronary artery contraction by vasoactive eicosanoids.
Kanashiro CA; Khalil RA
Can J Physiol Pharmacol; 1998 Dec; 76(12):1110-9. PubMed ID: 10326833
[TBL] [Abstract][Full Text] [Related]
9. Reactivity-based coronary vasospasm independent of atherosclerosis in rhesus monkeys.
Hermsmeyer K; Miyagawa K; Kelley ST; Rösch J; Hall AS; Axthelm MK; Greenberg B
J Am Coll Cardiol; 1997 Mar; 29(3):671-80. PubMed ID: 9060910
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-1 promotes Ca2+ antagonist-insensitive coronary smooth muscle contraction via activation of epsilon-protein kinase C.
McNair LL; Salamanca DA; Khalil RA
Hypertension; 2004 Apr; 43(4):897-904. PubMed ID: 14981072
[TBL] [Abstract][Full Text] [Related]
11. Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619.
Cocks TM; Kemp BK; Pruneau D; Angus JA
Br J Pharmacol; 1993 Sep; 110(1):360-8. PubMed ID: 8220898
[TBL] [Abstract][Full Text] [Related]
12. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
Kemp BK; Cocks TM
Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
[TBL] [Abstract][Full Text] [Related]
13. 17 beta-Estradiol inhibits Ca2+ influx and Ca2+ release induced by thromboxane A2 in porcine coronary artery.
Han SZ; Karaki H; Ouchi Y; Akishita M; Orimo H
Circulation; 1995 May; 91(10):2619-26. PubMed ID: 7743625
[TBL] [Abstract][Full Text] [Related]
14. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
[TBL] [Abstract][Full Text] [Related]
15. Estrogen restores postischemic sensitivity to the thromboxane mimetic U46619 in rat pial artery.
Qin X; Hurn PD; Littleton-Kearney MT
J Cereb Blood Flow Metab; 2005 Aug; 25(8):1041-6. PubMed ID: 15758945
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of 17beta-estradiol and testosterone on the contractile responses of porcine coronary arteries.
Teoh H; Quan A; Leung SW; Man RY
Br J Pharmacol; 2000 Apr; 129(7):1301-8. PubMed ID: 10742284
[TBL] [Abstract][Full Text] [Related]
17. Proliferative effects of combination estrogen and progesterone replacement therapy on the normal postmenopausal mammary gland in a murine model.
Raafat AM; Hofseth LJ; Haslam SZ
Am J Obstet Gynecol; 2001 Feb; 184(3):340-9. PubMed ID: 11228484
[TBL] [Abstract][Full Text] [Related]
18. Thromboxane A2-induced inhibition of voltage-gated K+ channels and pulmonary vasoconstriction: role of protein kinase Czeta.
Cogolludo A; Moreno L; Bosca L; Tamargo J; Perez-Vizcaino F
Circ Res; 2003 Oct; 93(7):656-63. PubMed ID: 12970114
[TBL] [Abstract][Full Text] [Related]
19. Ca2+ antagonist-insensitive coronary smooth muscle contraction involves activation of epsilon-protein kinase C-dependent pathway.
Dallas A; Khalil RA
Am J Physiol Cell Physiol; 2003 Dec; 285(6):C1454-63. PubMed ID: 14600078
[TBL] [Abstract][Full Text] [Related]
20. Endothelium-independent relaxation to raloxifene in porcine coronary artery.
Leung HS; Seto SW; Kwan YW; Leung FP; Au AL; Yung LM; Yao X; Huang Y
Eur J Pharmacol; 2007 Jan; 555(2-3):178-84. PubMed ID: 17113071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]